Diabetic macular oedema - fluocinolone acetonide intravitreal implant (rapid review of TA271) (TA301)
Fast, easy summary view of NICE guidance on 'diabetes'
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (rapid review of technology appraisal guidance 271)
- the implant is used in the eye with the artificial lens and
- their diabetic macular oedema has not got better with other treatments.
What does this mean for me?
If you have chronic diabetic macular oedema and your doctor thinks that fluocinolone acetonide intravitreal implant is the right treatment, you should be able to have the treatment on the NHS.
Fluocinolone acetonide intravitreal implants should be available on the NHS within 3 months of the guidance being issued.
This guidance replaces NICE technology appraisal guidance 271 (published January 2013). TA271 did not recommend fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema considered insufficiently responsive to available therapies. The updated guidance recommends fluocinolone acetonide intravitreal implant as an option for treating chronic diabetic macular oedema that is insufficiently responsive to available therapies only if the implant is to be used in an eye with an intraocular (pseudophakic) lens and the manufacturer provides fluocinolone acetonide intravitreal implant with the discount agreed in the patient access scheme.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: diabetes
This page was last updated: 11 December 2013
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.